Vaccines Archives

In Depth 17 Dec 2024

Ovarian cancer: BioNTech, Curelab, OvarianVax and more bring vaccines to the clinic

A number of ovarian cancer vaccines are being evaluated including the world’s first cancer prevention vaccine, which recently received funding.

December 17, 2024 - 9 minutesmins - By Roohi Mariam Peter

In Depth 2 Dec 2024

The rise of cancer vaccines: A new era in immunotherapy

Delve into the expanding and diverse field of cancer vaccines with various approaches exploiting the immune system to fight tumors.

December 2, 2024 - 8 minutesmins - By Jules Adam

Trump’s healthcare cabinet picks: Implications for U.S. biopharma

News and Trends 29 Nov 2024

Trump’s healthcare picks: Who they are and what they mean for the biopharma industry

Trump’s nominees for top healthcare roles have sparked significant debate. So, what do their appointments signal for the future of healthcare in the U.S.?

November 29, 2024 - 11 minutesmins - By Roohi Mariam Peter

In Depth 6 Nov 2024

Tuberculosis research: Are we finally close to developing a more effective treatment option?

Learn more about the positive advancements that have been made in tuberculosis research in an attempt to find new treatment options.

November 6, 2024 - 12 minutesmins - By Willow Shah-Neville

News and Trends 30 Sep 2024

The race for a bird flu vaccine: milestones and breakthroughs

The recent uptick in U.S. bird flu cases poses a threat to public health. Biotechs are now developing vaccines to mitigate the outbreak.

September 30, 2024 - 10 minutesmins - By Roohi Mariam Peter

With its molecular clamp technology and its lead multivalent vaccine candidate targeting both RSV and hMPV, Vicebio aims to solve unmet medical needs.

News and Trends 23 Sep 2024

Vicebio and its molecular clamp vaccine raise big to tackle respiratory viruses

Discover Vicebio’s molecular clamp technology as it completes a $100 million series B round for its bivalent vaccine against RSV and hMPV.

September 23, 2024 - 9 minutesmins - By Jules Adam

Podcast 30 Aug 2024

The future of combination vaccines

To look at combination vaccines, listen to our conversation with Cesar Sanz Rodriguez, vice president, Europe & Switzerland, medical affairs, at Moderna.

August 30, 2024

In Depth 9 Aug 2024

The therapeutic potential of circular RNA: Could it soon trump mRNA technology?

Find out about circular RNA, an emerging technology that could hold a lot of promise for next-generation vaccines and gene therapies.

August 9, 2024 - 5 minutesmins - By Willow Shah-Neville

News and Trends 29 Jul 2024

Influenza solution deals pile up as pandemic preparedness increases

Influenza deals have been piling up in the last few weeks. Discover why that is and how are companies and government preparing for pandemics.

July 29, 2024 - 6 minutesmins - By Jules Adam

In Depth 15 Jul 2024

Resources

Categories

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Vaccines

Ovarian cancer: BioNTech, Curelab, OvarianVax and more bring vaccines to the clinic

The rise of cancer vaccines: A new era in immunotherapy

Trump’s healthcare picks: Who they are and what they mean for the biopharma industry

Tuberculosis research: Are we finally close to developing a more effective treatment option?

The race for a bird flu vaccine: milestones and breakthroughs

Vicebio and its molecular clamp vaccine raise big to tackle respiratory viruses

The future of combination vaccines

The therapeutic potential of circular RNA: Could it soon trump mRNA technology?

Influenza solution deals pile up as pandemic preparedness increases

Fighting EEHV in elephants: How mRNA vaccines can offer hope against viruses affecting animals

Powering up biologics development using mammalian cell lines

Biologics testing: The right time to move to new standards?

Subscribe to our newsletter to get the latest biotech news!

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!